You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Erythropoietin (EPO) therapy effectively treated anemia in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Both intravenous and subcutaneous EPO improved patient well-being and partially corrected anemia with manageable side effects.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: